VisualSonics Appoints New President and CEO

TORONTO, Nov. 3 VisualSonics-new-CEO
TORONTO, Nov. 3 /PRNewswire/ - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro imaging systems, today announced that the Board of Directors has permanently appointed Anil Amlani, as President and Chief Executive Officer of the Company. Mr. Amlani, previously the Chief Financial Officer, has served as interim President and Chief Executive Office since May 2009.
"VisualSonics has aggressive growth plans to expand our base small animal business into human applications with our micro-ultrasound platform. The rollout of these new products and expansion of our small animal business requires experienced management," said Jeff Courtney, Chairman of VisualSonics, Inc. "Anil's expertise in the management of a diversified healthcare business supports our long term vision for VisualSonics as the world leader in the micro-imaging market."
Mr. Amlani, who joined VisualSonics in 2005, was previously responsible for the strategic direction of the Company by overseeing its short- and long-term operations and implementing corporate development, financial management and long-term business plans. Prior to joining VisualSonics, Mr. Amlani was Chief Operating Officer and Chief Financial Officer at MDS Proteomics and Senior Vice President and Chief Financial Officer at Cancom, where he successfully managed financings raising in excess of $600 million. He previously held senior positions at TD Bank including Head of Finance, Commercial and Retail Banking; and with AT&T Canada as Senior Vice President of Wholesale division and Strategic Planning and New Business Development. Mr. Amlani obtained his Chartered Accountancy designation in London, England and Canada.

    About VisualSonics
    ------------------

VisualSonics is the world leader in real time, in vivo, high-resolution micro imaging systems designed specifically for preclinical research. The Company's cutting edge technologies allow researchers at the world's most prestigious pharmaceutical and biotechnology companies, hospitals and universities to conduct research in cardiovascular, cancer, neurobiology and developmental biology areas. The micro imaging technologies support research applications that include genetic research, phenotypic studies and drug development. VisualSonics micro imaging platforms combine high-resolution, real time in vivo imaging at reasonable cost with ease-of-use and quantifiable results.
SOURCE VisualSonics Inc.